Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Non-Current Assets (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Non-Current Assets for 4 consecutive years, with $380135.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 28.26% to $380135.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 32.73% decrease, with the full-year FY2024 number at $373068.0, down 31.06% from a year prior.
  • Non-Current Assets was $380135.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $337583.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.7 million in Q2 2023 to a low of $198202.0 in Q4 2022.
  • A 4-year average of $514960.8 and a median of $380135.0 in 2025 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 173.05% in 2023, then plummeted 66.5% in 2024.
  • 60 Degrees Pharmaceuticals' Non-Current Assets stood at $198202.0 in 2022, then skyrocketed by 173.05% to $541183.0 in 2023, then crashed by 31.06% to $373068.0 in 2024, then rose by 1.89% to $380135.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Non-Current Assets are $380135.0 (Q3 2025), $337583.0 (Q2 2025), and $327636.0 (Q1 2025).